Utah Life Sciences News – Page 89

RECURSION ANNOUNCES MULTI-YEAR COLLABORATION WITH MILA FOR TECH-ENABLED DRUG DISCOVERY

Posted on July 5, 2021 by Denise Bell

Recursion has announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursion’s machine learning capabilities. Recursion will open office space within Mila and build a team focused on using machine learning for tech-enabled drug discovery. “Recursion is executing at the forefront of multiple technical fields including biology, chemistry, automation, engineering and […]

Epitel Publishes First Peer-Reviewed Research Paper

Posted on July 5, 2021 by Denise Bell

BioUtah congratulates the Epitel team on its first peer-reviewed manuscript, “Electrographic Seizure Monitoring with a Novel, Wireless, Single-Channel EEG Sensor,” comparing Epilog EEG to the clinical gold-standard of traditional EEG. The publication appears in Clinical Neurophysiology Practice. People living with epilepsy could benefit by having a more accurate and objective wearable EEG system for counting seizures […]

RenalytixAI’s KidneyIntelX™ Demonstrates Effectiveness In Monitoring Therapeutic Response in kidney health for Adults with type 2 diabetes

Posted on July 5, 2021 by Denise Bell

Renalytix has announced new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health in adults with type 2 diabetes. The data from an international study of 1,100 individuals with diabetic kidney disease (DKD) in the CANagliflozin Cardiovascular Assessment Study (CANVAS), was presented at the American Diabetes Association 81st Scientific Sessions […]

Webinar: New Non-dilutive Funding Resource for BioUtah Members

Posted on June 28, 2021 by admin

BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape. […]

Phoenix PharmaLabs Raises More than $1 Million for Continued Development of Non-Addictive Opioids

Posted on June 28, 2021 by Denise Bell

Phoenix PharmaLabs, Inc. has completed a second successful round of financing raising $1.07 million via the Netcapital equity funding portal to continue development of two non-addictive opioids to treat acute and chronic pain. “More than a thousand investors, many of whom invested in our previous funding, participated in this offering, indicating to us they did […]

Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test

Posted on June 28, 2021 by Denise Bell

Co-Diagnostics has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings. The Co-Diagnostics Logix Smart DS test kit detects the presence of certain genes of the COVID-19 virus directly from human saliva samples while eliminating RNA extraction of the samples. Eliminating […]

Turner Innovations Awarded STTR Phase 1 Contract from US Air Force

Posted on June 28, 2021 by Denise Bell

Turner Imaging Systems has won a small Business Technology Transfer (STTR) Phase I contract from the U.S. Air Force. Turner will use the non-dilutive funds to develop a next generation compact, highly portable, battery-powered full-body fluoroscopic X-ray (Smart-C) to help Special Operations Surgical Teams, Army Forward Surgical Teams (FSTs), and Navy Fleet Surgical Teams, save […]

Utah Life Sciences Companies Tout BioHive at Arab Health Trade Show

Posted on June 28, 2021 by Denise Bell

Organized by World Trade Center Utah and the Governor’s Office of Economic Development (GOED), eight Utah life sciences companies recently represented the state and our industry in Dubai, as part of the Arab Health trade show. The delegation exhibited in a booth showcasing the companies and BioHive. Quansys Biosciences, Turner Imaging Solutions and Zehn-X LLC, […]

Tula Health Raises $24.1 Million, Valuation Rises to $187 Million

Posted on June 28, 2021 by Denise Bell

Tula Health recently raised $24.1 million in debt and equity financing from two venture firms – Springtide Ventures, a health tech venture firm based in Utah and Boston, and Sandbox Capital Advisors based in Salt Lake City. The company creates behavioral change guidance via on-call support, and supporting hardware and software to help their customers […]

nView s1 Reaches its 50th Surgery, Gets Navigation Capability

Posted on June 28, 2021 by Denise Bell

The nView s1, nView medical’s breakthrough imaging system, reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. nView medical CEO, Cristian Atria, said, “To celebrate the 50th surgery milestone we gave the nView s1 […]

Launch of Xenter Therapeutics

Posted on June 28, 2021 by Denise Bell

Following the close of $12M in Series A funding, Xenter, Inc., the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics business unit. Xenter Therapeutics will lead the therapeutic drug element of Xenter’s mission and vision and is headed by President and Xenter board member David J. Bearss, PhD, a biotech […]

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Posted on June 22, 2021 by Denise Bell

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]